Drugs for Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 191)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Captopril |
Approved |
Phase 4 |
|
62571-86-2 |
44093 |
Synonyms:
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylate
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylate
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
Acediur
Aceplus
Acepress
ACEPRIL
Alopresin
Apopril
C09AA01
Capoten
Capoten®|SQ-14225
Captolane
CAPTOMEX
CAPTOPRIL
Captoprilum
Captoprilum [INN-Latin]
Captopryl
Captoril
Cesplon
|
CP
D-2-Methyl-3-mercaptopropanoyl-L-proline
D-3-Mercapto-2-methylpropanoyl-L-proline
Dilabar
ECOPACE
Garranil
Hipertil
Hypertil
HYTENEZE 12.5
HYTENEZE 25
HYTENEZE 50
KAPLON
L-Captopril
Lopirin
LOPRIL
NOYADA
SA-333
SQ -14225
SQ-14225
Tenosbon
Tensobon
Tensoprel
|
|
2 |
|
Ethiodized oil |
Approved, Investigational |
Phase 4 |
|
8008-53-5 |
|
Synonyms:
|
3 |
|
Parecoxib |
Approved |
Phase 4 |
|
198470-84-7 |
119828 |
Synonyms:
Dynastat
N-(((5-Methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide
N-(((5-Methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt
N-(((Me-P)-P)S)P
N-((p-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide
N-((p-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulphonyl)propionamide
|
PARECOXIB
Parécoxib
Parecoxib sodium
Parecoxibum
SC 69124
SC-69124
|
|
4 |
|
Sufentanil |
Approved, Investigational |
Phase 4 |
|
56030-54-7 |
41693 |
Synonyms:
Chronogesic
Citrate, sufentanil
Curasan brand OF sufentanil citrate
Curasan, sufentanil
Hameln brand OF sufentanil citrate
IDS-NS-001
Janssen brand OF sufentanil citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
R-30730
Ratiopharm brand OF sufentanil citrate
Sufenta
Sufenta®|sufentanil citrate|Zalviso®
Sufentanil
Sufentanil citrate
|
Sufentanil curasan
Sufentanil hameln
Sufentanil ratiopharm
Sufentanil-hameln
SufentanilHameln
Sufentanilo
Sufentanil-ratiopharm
SufentanilRatiopharm
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanil Citrate
Sulfentanyl
Taylor brand OF sufentanil citrate
|
|
5 |
|
Timolol |
Approved |
Phase 4 |
|
26839-75-8 |
5478 33624 |
Synonyms:
(-)-S-TIMOLOL
(S)-1-(TERT-BUTYLAMINO)-3-[(4-MORPHOLIN-4-YL-1,2,5-THIADIAZOL-3-YL)OXY]PROPAN-2-OL
Apo-Timol
Apo-Timop
Aquanil
BETIM
BETIMOL
BLOCADREN
GLAUCOL
GLAU-OPT
ISTALOL
Novo-Timol
Nu-Timolol
NYO142
NYOGEL
Phoxal-timolol
Proflax
Temserin
Tenopt
|
Timacar
Timacor
Tim-AK
TIMOLOL
TIMOLOL ANHYDROUS
TIMOLOL HEMIHYDRATE
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
TIMOPTIC
Timoptic in Ocudose
Timoptic OcuDose
Timoptic®
TIMOPTIC-XE
Timoptol
TIOPEX
|
|
6 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
6473866 445643 |
Synonyms:
(-)-FK 506
Anhydrous tacrolimus
Anhydrous, tacrolimus
Cilag brand OF tacrolimus
FK5
FK506
FK-506
FK506|fujimycin|Prograf®|Protopic®
FR-900506
FUJIMYCIN
Fujisawa brand OF tacrolimus
Janssen brand OF tacrolimus
|
K506
LCP-Tacro
Prograf
Prograft
PROTOPIC
Tacarolimus
TACROLIMUS
Tacrolimus anhydrous
tacrolimus hydrate
TACROLIMUS MONOHYDRATE
Tacrolimus, anhydrous
|
|
7 |
|
Atenolol |
Approved |
Phase 4 |
|
29122-68-7 |
2249 |
Synonyms:
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
Aircrit
Alinor
Altol
Anselol
Antipressan
Apo-atenolol
Atcardil
Atecard
Atehexal
ATENAMIN
Atenblock
Atendol
Atenet
Ateni
Atenil
ATENIX-100
ATENIX-25
ATENIX-50
Atenol
Atenol 1a pharma
Atenol acis
Atenol al
Atenol atid
Atenol cophar
Atenol CT
Atenol fecofar
Atenol gador
Atenol genericon
Atenol GNR
Atenol heumann
Atenol MSD
Atenol NM pharma
Atenol nordic
Atenol PB
Atenol quesada
Atenol stada
Atenol tika
Atenol trom
Atenol von CT
Atenolin
Atenol-mepha
Atenolol
ATENOLOL (JAN/USP)
ATENOLOL [USAN:BAN:INN:JAN]
Atenololum
ATENOLOLUM [INN-LATIN]
Atenol-ratiopharm
Atenol-wolff
Atenomel
Atereal
Aterol
Betablok
Betacard
Betasyn
Betatop ge
Blocotenol
Blokium
C07AB03
Cardaxen
|
Cardiopress
Corotenol
Cuxanorm
Duraatenolol
Duratenol
ESATENOLOL
Evitocor
Farnormin
Felo-bits
Hipres
Hypoten
Ibinolo
ICI 66082
ICI-66082
Internolol
Jenatenol
Juvental
KENTOL
Loten
Lo-ten
Lotenal
Myocord
Myocord®|Normiten®|Tenormin®
Normalol
Normiten
Noten
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
Scheinpharm atenol
Seles beta
Selobloc
Serten
Servitenol
Stermin
Tenidon
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
TENORMIN 25
TENORMIN L.S.
Tenormine
TENORMINE [FRENCH]
Tensimin
TOTAMOL
Tredol
Unibloc
Uniloc
VASATEN
Vascoten
Vericordin
Wesipin
Xaten
|
|
8 |
|
Medroxyprogesterone acetate |
Approved, Investigational |
Phase 4 |
|
520-85-4, 71-58-9 |
6279 10631 |
Synonyms:
(6ALPHA)-17-(ACETYLOXY)-6-METHYLPREG-4-ENE-3,20-DIONE
(6α)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17 alpha Hydroxy 6 alpha methylprogesterone
17 alpha-Hydroxy-6 alpha-methylprogesterone
17-ACETOXY-6ALPHA-METHYLPROGESTERONE
17-ACETOXY-6Α-METHYLPROGESTERONE
17a-Hydroxy-6a-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone
17ALPHA-HYDROXY-6ALPHA-METHYLPROGESTERONE ACETATE
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17-Hydroxy-6a-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6a-methylprogesterone
17-Hydroxy-6α-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6α-methylprogesterone
17Α-hydroxy-6α-methylprogesterone
17Α-HYDROXY-6Α-METHYLPROGESTERONE ACETATE
6ALPHA-METHYL-17-ACETOXY PROGESTERONE
6-ALPHA-METHYL-17-ALPHA-ACETOXYPROGESTERONE
6alpha-Methyl-17alpha-hydroxyprogesterone
6ALPHA-METHYL-17ALPHA-HYDROXYPROGESTERONE ACETATE
6-ALPHA-METHYL-17-ALPHA-HYDROXYPROGESTERONE ACETATE
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6ALPHA-METHYL-4-PREGNENE-3,20-DION-17ALPHA-OL ACETATE
6a-Methyl-17a-hydroxyprogesterone
6a-Methyl-4-pregnen-17a-ol-3,20-dione
6Α-METHYL-17-ACETOXY PROGESTERONE
6Α-methyl-17α-hydroxyprogesterone
6Α-METHYL-17Α-HYDROXYPROGESTERONE ACETATE
6Α-methyl-4-pregnen-17α-ol-3,20-dione
6α-Methyl-4-pregnene-3,20-dion-17α-ol acetate
ADGYN MEDRO
AMEN
Aragest
Aragest 5
Asconale
CBP-1011
CLIMANOR
Clinofem
Clinovir
Colirest
CURRETAB
CYCRIN
Depo-Clinovir
Depo-Prodasone
Depo-Progestin
DEPO-PROGEVERA
Depo-Promone
DEPO-PROVERA
DEPO-PROVERA ONCOLOGY
DEPO-SUBQ PROVERA 104
Depot-Medroxyprogesterone acetate
DMPA
FARLUTAL
FARLUTAL 100
FARLUTAL 200
FARLUTAL 250
FARLUTAL 500
Farlutal inyectable
|
Farlutin
Gestapuran
G-Farlutal
Hematrol
Hydroxymethylprogesterone
hydroxymethylprogesterone|MPA
Hysron
Indivina
LUNELLE
Lutopolar
Lutoral
MAP
Med-Pro
Medroprogesterone Acetate
Medrossiprogesterone
Medrossiprogesterone [Dcit]
Medroxiprogesterona
Medroxiprogesterona [INN-Spanish]
MEDROXIPROGESTERONE ACETATE
Medroxiprogesteronum
MEDROXYACETATE PROGESTERONE
Medroxyprogesteron
Medroxyprogesteron acetate
MEDROXYPROGESTERONE
MEDROXYPROGESTERONE 17-ACETATE
MEDROXYPROGESTERONE ACETATE
Medroxyprogesterone strakan brand
Medroxyprogesteronum
Medroxyprogesteronum [INN-Latin]
Meprate
METHYLACETOXYPROGESTERONE
Methylhydroxyprogesterone
METIGESTRONA
MPA
MPA Gyn 5
Nadigest
Nidaxin
Novo-Medrone
NSC-21171
NSC-26386
Oragest
Perlutex
Perlutex Leo
PREMPRO
Prodasone
Progestalfa
Progevera
PROVERA
Proverone
Ralovera
Repromap
Repromix
SAYANA PRESS
Sirprogen
Sodelut G
Strakan brand OF medroxyprogesterone
TV-46046
Veramix
|
|
9 |
|
Progesterone |
Approved, Vet_approved |
Phase 4 |
|
57-83-0 |
5994 |
Synonyms:
(1S,2R,10S,11S,14S,15S)-14-ACETYL-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
(8S,9S,10R,13S,14S,17S)-17-ACETYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9S,10R,13S,14S,17S)-17-ETHANOYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(S)-4-PREGNENE-3,20-DIONE
(S)-PREGN-4-EN-3,20-DIONE
(S)-PROGESTERONE
17ALPHA-PROGESTERONE
17A-PROGESTERONE
17Α-PROGESTERONE
3,20-PREGNENE-4
4-PREGNEN-3,20-DIONE
4-PREGNENE-3,20-DIONE
AGOLUTIN
AKROLUTIN
Amen
BETA-PROGESTERONE
BIO-LUTON
CIDR
COLPROSTERONE
CORLUTIN
CORLUTINA
CORLUVITE
CORPORIN
CORPUS LUTEUM HORMONE
CRINONE
CRINONE PROGESTERONE GEL
CURRETAB
CYCLOGEST
CYCLOGESTERIN
Cycrin
D4-PREGNENE-3,20-DIONE
DELALUTIN
DELTA(4)-PREGNENE-3,20-DIONE
DELTA(SUP 4)-PREGNENE-3,20-DIONE
DURAPROGEN
ENDOMETRIN
ESTIMA
FLAVOLUTAN
FOLOGENON
Gelbkoerperhormon
GELBKÖRPERHORMON
GESTEROL
GESTEROL 100
GESTEROL 50
GESTIRON
GESTONE
GESTORMONE
GESTRON
GLANDUCORPIN
GYNLUTIN
GYNOLUTON
GYNOLUTONE
HORMOFLAVEINE
HORMOLUTON
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
LINGUSORBS
LIPO-LUTIN
LUCORTEUM
LUCORTEUM SOL
LUGESTERON
LUTEAL HORMONE
Luteinique
LUTEOCRIN NORMALE
LUTEODYN
LUTEOGAN
LUTEOHORMONE
LUTEOL
LUTEOPUR
LUTEOSAN
LUTEOSTAB
LUTEOVIS
LUTEUM
LUTEX
LUTIDON
LUTIGEST
|
Lutin
LUTOCICLINA
LUTOCUCLIN M
LUTOCYCLIN
LUTOCYCLIN M
LUTOCYLIN
LUTOCYLOL
LUTOFORM
LUTOGYL
LUTOGYNON
LUTREN
LUTROMONE
MEMBRETTES
METHYLPREGNONE
MPA
NALUTRON
NSC-64377
NSC-9704
PERCUTACRINE
PERCUTACRINE LUTEINIQUE
PIAPONON
PRANONE
PREGN-4-EN-3,20-DIONE
PREGN-4-ENE-3,20-DIONE
PREGNENE-3,20-DIONE
PREGNENEDIONE
PRIMOLUT
PROCHIEVE
PROGEFFIK
PROGEKAN
PROGESTA-CARE
PROGESTAN
PROGESTASERT
PROGESTEROL
PROGESTERON
PROGESTERONA
Progesterona [INN-Spanish]
PROGESTERONE
PROGESTÉRONE
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
PROGESTERONUM
Progesteronum [INN-Latin]
PROGESTIN
PROGESTOGEL
PROGESTOL
PROGESTON
PROGESTONE
PROGESTOSOL
PROGESTRON
PROGESTRONOL
PROJESTAJECT
PROLETS
PROLIDON
PROLUTIN
PROLUTON
PROLUTONE
PROMETRIUM
Prometrium®|Utrogestan®
PRONTOGEST
PROTORMONE
REGUMATE
SERENITY FOR WOMEN
SYNGESTERONE
SYNGESTRETS
SYNGESTRONE
SYNOVEX S
SYNTOLUTAN
Thiuram E
Thiuranide
U 3672
UTROGEST
UTROGESTAN
VITARRINE
Δ(4)-pregnene-3,20-dione
|
|
10 |
|
Angiotensin-Converting Enzyme Inhibitors |
|
Phase 4 |
|
|
|
11 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
12 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
13 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
14 |
|
Dsuvia |
|
Phase 4 |
|
|
|
15 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
16 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 4 |
|
|
|
17 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
18 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
19 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
20 |
|
Ophthalmic Solutions |
|
Phase 4 |
|
|
|
21 |
|
Anesthetics |
|
Phase 4 |
|
|
|
22 |
|
Calcineurin Inhibitors |
|
Phase 4 |
|
|
|
23 |
|
Adrenergic beta-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
24 |
|
Sympatholytics |
|
Phase 4 |
|
|
|
25 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
26 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
27 |
|
Contraceptives, Oral, Hormonal |
|
Phase 4 |
|
|
|
28 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
29 |
|
Contraceptive Agents, Male |
|
Phase 4 |
|
|
|
30 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
31 |
|
Nadolol |
Approved |
Phase 3 |
|
42200-33-9 |
39147 |
Synonyms:
Corgard
Corgard®|corzide|SQ-11725
CORZIDE
|
|
|
32 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 3 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
33 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 3 |
|
52-21-1 |
|
Synonyms:
ECONOPRED
FLO-PRED
METICORTELONE
NSC-10966
OMNIPRED
PRED FORTE
|
PRED FTE
PRED MILD
PREDNISOLONE 21-ACETATE
PREDNISOLONE ACETATE
STERANE
ULTRACORTENOL
|
|
34 |
|
Prednisolone |
Approved, Vet_approved |
Phase 3 |
|
50-24-8 |
4894 5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11Β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
3,20-Dioxo-11b,17a,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Codelcortone
Co-Hydeltra
Cordrol
CORTALONE
Cotogesic
Cotolone
Decaprednil
Decortin H
DEKOTIL
Delcortol
Delta F
Delta(1)-Dehydrocortisol
Delta(1)-Dehydrohydrocortisone
Delta(1)-Hydrocortisone
DELTA.1-CORTISOL
DELTA.1-Cortisol|Orapred®|Pediapred®
Delta-Cortef
Deltacortenol
DELTACORTRIL
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
Deltahydrocortisone
DELTALONE
Deltasolone
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
DESOWEN
Dexa-Cortidelt Hostacortin H
Di adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Dicortol
DILACORT
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
FERNISOLONE-P
Flamasone
Hostacortin H
HYDELTRA
Hydeltrasol
HYDELTRA-TBA
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
IMS904
Inflamase Forte
Inflamase Mild
I-Pred
Key-Pred
Klismacort
Lentosone
Lite Pred
Medrol
|
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
METICORTELONE
METI-DERM
Metreton
M-Predrol
NEO-DELTA-CORTEF
Nisolone
Nor-Pred T.B.A.
NSC-9120
NSC-9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
ORAPRED
Panafcortelone
Paracortol
Paracotol
PEDIAPRED
PEVANTI
POLY-PRED
PRDL
Precortalon
Precortancyl
Precortilon
PRECORTISYL
PRECORTISYL FTE
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
PREDL
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone acetate
Prednisolone sodium phosphate
Prednisolone tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
PRELONE
Prenolone
Rolisone
SCHERIPROCT
Scherisolon
SERVISONE
Solone
Steran
STERANE
Sterolone
Supercortisol
TRIDESILON
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
VERDESO
Δ(1)-dehydrocortisol
Δ(1)-dehydrohydrocortisone
Δ(1)-hydrocortisone
Δ-cortef
|
|
35 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 3 |
|
2921-57-5 |
1875 |
Synonyms:
Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinic acid
|
Methylprednisolone hydrogen succinate
Methylprednisolone succinate
|
|
36 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 3 |
|
83-43-2 |
4159 6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6Α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
1-Dehydro-6alpha-methylhydrocortisone
1-Dehydro-6a-methylhydrocortisone
1-Dehydro-6α-methylhydrocortisone
6 Methylprednisolone
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6a-Methylprednisolone
6-Methylprednisolone
6Α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
6Α-methylprednisolone
Artisone-Wyeth
Besonia
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
Dopomedrol
Esametone
Firmacort
J3.872E
Lemod
Medesone
Medixon
Medlone 21
Medrate
Medric acid
Medrol
Medrol Adt Pak
Medrol Dosepak
Medrol®|U-67590A
Medrone
Mesopren
|
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
Nirypan
Noretona
NSC-19987
Predni N Tablinen
Promacortine
Reactenol
Sieropresol
Solomet
SOLU-MEDROL
Summicort
Suprametil
U-67590A
Urbason
Urbasone
Wyacort
Δ(1)-6a-methylhydrocortisone
Δ(1)-6α-methylhydrocortisone
|
|
37 |
|
Acebutolol |
Approved, Investigational |
Phase 3 |
|
37517-30-9 |
1978 |
Synonyms:
(+-)-Acebutolol
(±)-ACEBUTOLOL
3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide
5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone
ACEBUTOLOL
Acebutolol gepepharm brand
Acebutolol HCL
Acebutolol heumann
Acebutolol hydrochloride
Acébutolol ratiopharm
Acebutololo
Acébutololratiopharm
Acébutolol-ratiopharm
Acebutololum
Acetobutolol
Apo acebutolol
Apo-acebutolol
ApoAcebutolol
Apotex brand OF acebutolol hydrochloride
Bayer brand OF acebutolol hydrochloride
C07AB04
DL-Acebutolol
Gepepharm brand OF acebutolol
Heumann brand OF acebutolol hydrochloride
Heumann, acebutolol
Hydrochloride, acebutolol
|
IL-17803A
IL-17803A|Sectral®
Italfarmaco brand OF acebutolol hydrochloride
Lafon ratiopharm brand OF acebutolol hydrochloride
Lafon-ratiopharm brand OF acebutolol hydrochloride
m And b 17803 a
m And b 17803a
m And b17803 a
m And b-17803 a
Monitan
N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide
N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide
Neptal
Novo acebutolol
Novo-acebutolol
NovoAcebutolol
Novopharm brand OF acebutolol hydrochloride
Prent
Proctor and gamble brand OF acebutolol hydrochloride
Rhodiapharm brand OF acebutolol hydrochloride
Rhône poulenc rorer brand OF acebutolol hydrochloride
Rhône-poulenc rorer brand OF acebutolol hydrochloride
Rhotral
Sectral
Specia brand OF acebutolol hydrochloride
Wyeth brand OF acebutolol hydrochloride
|
|
38 |
|
Maleic acid |
Experimental, Investigational |
Phase 3 |
|
110-16-7, 110-17-8 |
444266 444972 |
Synonyms:
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(2Z)-2-Butenedioate
(2Z)-2-Butenedioic acid
(2Z)-But-2-enedioate
(2Z)-But-2-enedioic acid
(2Z)-Butene-2-dioate
(2Z)-Butene-2-dioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
(Z)-2-Butenedioate
(Z)-2-Butenedioic acid
(Z)-Butenedioate
(Z)-Butenedioic acid
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2-Butenedioate
2-Butenedioic acid
Allomaleate
Allomaleic acid
Boletate
Boletic acid
cis-1,2-Ethylenedicarboxylate
cis-1,2-Ethylenedicarboxylic acid
cis-2-Butenedioate
cis-2-Butenedioic acid
cis-But-2-enedioate
cis-But-2-enedioic acid
cis-Butenedioate
cis-Butenedioic acid
e297
FC 33
Fumarate
Fumaric acid
Fumaricum acidum
Fumarsaeure
|
Fumarsäure
Furamag
H2Male
Hydrogen maleate
Kyselina maleinova
Lichenate
Lichenic acid
MAE
Mafusol
Maleate
MALEIC ACID
Maleic acid, ammonium salt
Maleic acid, calcium salt
Maleic acid, dipotassium salt
Maleic acid, disodium salt
Maleic acid, iron salt
Maleic acid, monoammonium salt
Maleic acid, monocopper (2+) salt
Maleic acid, monosodium salt
Maleic acid, neodymium salt
Maleic acid, potassium salt
Maleic acid, sodium salt
Maleinic acid
Malenic acid
Malezid CM
Scotchbond multipurpose etchant
Sodium maleate
Toxilate
Toxilic acid
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
|
|
39 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 3 |
|
2920-86-7 |
4897 |
Synonyms:
(+)-prednisolone hemisuccinate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethoxy)-4-oxobutanoate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
PREDNISOLONE HEMISUCCINATE
Prednisolone hemisuccinic acid
Prednisolone hydrogen succinate
PREDNISOLONE SUCCINATE
|
|
40 |
|
Adrenergic beta-Antagonists |
|
Phase 3 |
|
|
|
41 |
|
Adrenergic Antagonists |
|
Phase 3 |
|
|
|
42 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
43 |
|
Adrenergic Agents |
|
Phase 3 |
|
|
|
44 |
|
Anti-Arrhythmia Agents |
|
Phase 3 |
|
|
|
45 |
|
Antihypertensive Agents |
|
Phase 3 |
|
|
|
46 |
|
Hormones |
|
Phase 3 |
|
|
|
47 |
|
Hormone Antagonists |
|
Phase 3 |
|
|
|
48 |
|
glucocorticoids |
|
Phase 3 |
|
|
|
49 |
|
Anti-Inflammatory Agents |
|
Phase 3 |
|
|
|
50 |
|
Methylprednisolone Acetate |
|
Phase 3 |
|
|
584547 |
Synonyms:
Acetyl methylprednisolone
Acetyl-methylprednisolone
DEPMEDALONE
Depo medrol
Depo medrone
Depo-medrol
Depo-medrone
|
MEDROL ACETATE
Methylprednisolone 21 acetate
METHYLPREDNISOLONE ACETATE
Methylprednisolone acetate, (11beta,16alpha)-isomer
Methylprednisolone acetate, (11beta,16beta)-isomer
Methylprednisolone acetic acid
Methylprednisolone-21-acetate
|
|
Interventional clinical trials:
(show top 50)
(show all 191)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma |
Unknown status |
NCT04288700 |
Phase 4 |
oral propranolol;Oral Captopril;intralesional propranolol injection;topical Timolol maleate 0.5% eye drops |
2 |
Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. A Phase IV Study. |
Unknown status |
NCT02625389 |
Phase 4 |
Lipiodol® Ultra Fluid with surgical glues |
3 |
A Randomized, Phase IV Study Exploring the Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy |
Unknown status |
NCT02204878 |
Phase 4 |
Parecoxib Sodium |
4 |
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma |
Completed |
NCT01908972 |
Phase 4 |
Prednisolone;Propranolol |
5 |
A Pilot Study of Hemoporfin Photodynamic Therapy in Children (7-14 Years Old) With Port-wine Stain |
Completed |
NCT03125057 |
Phase 4 |
Hemoporfin PDT |
6 |
DOUBLE-SKIN: a New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology: a Randomised, Double-blind, Placebo-controlled Trial |
Completed |
NCT04999618 |
Phase 4 |
Haemoblock |
7 |
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas |
Recruiting |
NCT05479123 |
Phase 4 |
Propranolol three times a day;Propranolol twice a day;Timolol |
8 |
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open Trial |
Recruiting |
NCT04077515 |
Phase 4 |
Sirolimus(0.8mg/m2);Sirolimus(0.7mg/m2) |
9 |
A Pilot Study of Hemoporfin Photodynamic Therapy in Children (2-7 Years Old) With Port-wine Stain |
Recruiting |
NCT04106258 |
Phase 4 |
Hemoporfin PDT |
10 |
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma: a Single Arm Prospective Study |
Recruiting |
NCT04056962 |
Phase 4 |
Tacrolimus ointment |
11 |
Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain |
Active, not recruiting |
NCT03181984 |
Phase 4 |
Hemoporfin |
12 |
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma: a Prospective Cohort Study |
Enrolling by invitation |
NCT05106179 |
Phase 4 |
Atenolol Pill;Propranolol Pill |
13 |
Management of Uterine Arteriovenous Malformation- a Comparison of 2 Management Possibilities- Observation vs. Progesterone Treatment/ a Randomized Control Trial |
Not yet recruiting |
NCT05491343 |
Phase 4 |
MedroxyPROGESTERone Injection [Depo-Provera] |
14 |
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas |
Unknown status |
NCT03237637 |
Phase 3 |
oral propranolol;oral atenolol |
15 |
Treatment of Cutaneous Hemangioma of Infancy With Topical 0.5% Timolol Maleate Eye Drop Compared With Placebo in Pediatric Patients, Siriraj Hospital |
Unknown status |
NCT01685398 |
Phase 3 |
0.5% timolol maleate eye drop;Normal saline |
16 |
CyberKnife Based Hypofractionated Radiotherapy Versus Conventional Linac Based Radiotherapy for Painful Vertebral Hemangiomas - Controlled Randomized Clinical Trial. |
Unknown status |
NCT02332408 |
Phase 3 |
|
17 |
Blood Oxygen Level Dependent fMRI Navigation for Function Protection in Intracranial Arteriovenous Malformation Surgery: a Multicenter Prospective Randomized Controlled Single Blind Clinical Trial |
Unknown status |
NCT01758211 |
Phase 3 |
|
18 |
Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel |
Unknown status |
NCT01272609 |
Phase 3 |
Timolol + LCP |
19 |
Nadolol Versus Propranolol in Children With Infantile Hemangiomas: a Randomized, Controlled, Double-blinded Trial |
Completed |
NCT02505971 |
Phase 3 |
Nadolol;Propranolol |
20 |
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma |
Completed |
NCT02342275 |
Phase 3 |
Propranolol;Atenolol |
21 |
A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants With Proliferating Infantile Hemangiomas (IHs) Requiring Systemic Therapy to Compare 4 Regimens of Propranolol (1 or 3 mg/kg/Day for 3 or 6 Months) to Placebo (Double Blind). |
Completed |
NCT01056341 |
Phase 2, Phase 3 |
Propranolol;Placebo |
22 |
A Randomized Trial of Unruptured Brain Arteriovenous Malformations |
Completed |
NCT00389181 |
Phase 3 |
|
23 |
A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation |
Completed |
NCT01677624 |
Phase 3 |
|
24 |
The Efficacy and Safety of Intravenous Pulse Steroids Compared to Standard Oral Steroids in the Treatment of Problematic Hemangiomas in Infants: A Randomized Controlled Trial |
Completed |
NCT00312520 |
Phase 3 |
prednisolone;methylprednisolone |
25 |
Double Blind, Randomised, Placebo-controlled Study of Propranolol in Infantile Capillary Hemangiomas |
Terminated |
NCT00744185 |
Phase 2, Phase 3 |
propranolol treatment;placebo treatment |
26 |
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma |
Terminated |
NCT01743885 |
Phase 3 |
Acebutolol;Propanolol |
27 |
'' Efficacy of Propranolol in the Treatment of Infantile Hemangioma" |
Unknown status |
NCT04684667 |
Phase 2 |
Propranolol Therapy for Infantile Hemangioma |
28 |
Effect of Oral Propranolol on mRNA Expression in Symptomatice Caavernous Malformation |
Unknown status |
NCT03474614 |
Phase 2 |
Propranolol |
29 |
Topical Timolol Gel for the Treatment of Infantile Hemangiomas |
Completed |
NCT02145884 |
Phase 2 |
timolol maleate 0.5% gel |
30 |
Efficacy and Safety of Topical Timolol Maleate 0.5% Solution for Superficial Infantile Hemangioma in Early Proliferative Phase. A Randomized Clinical Trial |
Completed |
NCT02731287 |
Phase 2 |
Timolol;Placebo |
31 |
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy |
Completed |
NCT00601016 |
Phase 2 |
Imiquimod 5% cream |
32 |
Nadolol for Proliferating Infantile Hemangiomas: A Prospective Open Label Study With a Historical Control |
Completed |
NCT01010308 |
Phase 2 |
Nadolol |
33 |
A Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Proliferative and Involuting Cutaneous Infantile Hemangioma |
Completed |
NCT01072045 |
Phase 2 |
Propranolol;Prednisone |
34 |
Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH) |
Completed |
NCT02913612 |
Phase 2 |
0.25% Timolol Maleate Gel Forming Solution;0.5% Timolol Maleate Gel Forming Solution |
35 |
A Randomised, Double Blind, Controlled, Multicentre Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo. |
Completed |
NCT01512173 |
Phase 2 |
propranolol gel;Placebo |
36 |
U.S. Multicenter, Randomized Controlled Study Comparing the Performance fo Onyx(EVOH) and TRUFILL® (n-BCA)in Presurgical Embolization of Brain Arteriovenous Malformations (BAVMs) |
Completed |
NCT00857662 |
Phase 2 |
|
37 |
Phase II Clinical Trial is to Compare Epidermal Temperature Measurements During 1.Laser Treatment at Standard Treatment Energies 2.Cryogen Spray Cooling (CSC) Plus Laser Treatment. 3.Contact Cooling Plus Laser Treatment. |
Completed |
NCT00540917 |
Phase 2 |
|
38 |
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding |
Completed |
NCT00389935 |
Phase 2 |
Thalidomide |
39 |
Treat_CCM Clinical Trial A Multicenter Randomized Clinical Trial on Propranolol in Familial Cerebral Cavernous Malformation |
Completed |
NCT03589014 |
Phase 2 |
Propranolol |
40 |
Treatment of Port-wine Stains by Bosentan in Addition to Pulsed Dye Laser (PDL) in Children or Young Adults Who Previously Failed to Respond to PDL Alone: a Monocentric Pilot Study |
Completed |
NCT02317679 |
Phase 2 |
Bosentan |
41 |
Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma |
Recruiting |
NCT03633747 |
Phase 1, Phase 2 |
Propranolol Hydrochloride |
42 |
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations |
Recruiting |
NCT02042326 |
Phase 2 |
Sirolimus |
43 |
COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arteriovenous Malformations (AVM) |
Recruiting |
NCT05125471 |
Phase 2 |
Cobimetinib |
44 |
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of REC-994 in the Treatment of Symptomatic Cerebral Cavernous Malformation |
Recruiting |
NCT05085561 |
Phase 2 |
REC-994;Placebo |
45 |
Phase I-II Randomized, Placebo-Controlled, Single-Blinded, Single-Site Clinical Trial of Atorvastatin in the Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) |
Active, not recruiting |
NCT02603328 |
Phase 1, Phase 2 |
Atorvastatin |
46 |
Lovastatin for Treatment of Brain Arteriovenous Malformations:a Double-blind, Placebo-controlled Randomized Trial |
Not yet recruiting |
NCT04297033 |
Phase 2 |
Lovastatin;Placebo |
47 |
A Multi-Center, Randomized Study to Evaluate the Efficacy and Safety of Light Dose (Fluence) in Subjects With Port Wine Stain Treated With Hemoporfin + Green Light Photodynamic Therapy |
Not yet recruiting |
NCT05171894 |
Phase 2 |
Hemopfin+PDF;Vehicle+PDF |
48 |
A Phase II, Randomized, Double-Blind Comparison of Corticosteroid and Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) |
Terminated |
NCT01074437 |
Phase 2 |
Prednisolone (Corticosteroid);Propranolol;Placebo |
49 |
A Phase II, Randomized, Clinical Trial Assessing Efficacy And Safety Of Oral Prednisolone vs Intravenous Vincristine In The Treatment Of Infantile |
Terminated |
NCT00555464 |
Phase 2 |
Vincristine;Prednisone |
50 |
Propranolol vs Prednisolone for Infant Hemangiomas-A Clinical and Molecular Study |
Terminated |
NCT00967226 |
Phase 2 |
propranolol;Prednisolone |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Interferon Alfa-2a
Interferon Alfa-2b
INTERFERON ALFA-3N,HUMAN LEUKOCYTE DERIVED
interferon alfacon-1
Interferon gamma-1b
|
Interferons
peginterferon alfa-2a
peginterferon alfa-2b
Recombinant interferon beta-1a
Recombinant interferon beta-1b
|
Cochrane evidence based reviews: hemangioma
|